Fabio S Ryser
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 02, 2025
Dupilumab Treatment Is Associated With Clinical Improvement and a Shift Toward a Health-Associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis.Fabio S Ryser, Tomas Demeter, Judith Bergada Pijuan
|Jan 29, 2025
Why Anti-IL-17 Therapy Fails: The Role of Autonomous IL-17R Signaling in Autoimmune Inflammation.Fabio S Ryser, Joseena Iype, Lisa Christ
|Jan 17, 2025
Editorial comment on "Association between nasopharyngeal airway lipidome signatures of infants with severe bronchiolitis and risk of recurrent wheeze: A prospective multicenter cohort study".Fabio S Ryser, Ömer Kalayci, Philippe Eigenmann
|Aug 07, 2023
Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis.Fabio S Ryser, Ayla Yalamanoglu, Alan Valaperti
Pageof 1
Frequent Collaborators
3 joint publications
Urs C Steiner
2 joint publications
Tina Mauthe
2 joint publications
Michael B Soyka
1 joint publications
Philippe Eigenmann
1 joint publications
Joseena Iype
1 joint publications
Lisa Christ
1 joint publications
Tomas Demeter
1 joint publications
Judith Bergada Pijuan
1 joint publications
Srikanth Mairpady Shambat
1 joint publications
Markus Hilty